To accelerate clinical development and global access to critical vaccines for children ...

A patient developed granulomatosis with polyangiitis (GPA), a type of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), following a long-standing history of systemic lupus ...

Therapeutic drug monitoring would seem like an obvious match with rheumatology. Patients with clinically challenging ...

To further expand its global presence and ensure widespread vaccine availability, SII has established Serum Life Sciences Ltd, a subsidiary in the UK. Through relentless pursuit of innovation, SII ...

What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...

TG Therapeutics, Inc. (“TG” or “the Company”), (NASDAQ: TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl ...

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...

Background Adalimumab is an effective first-line biologic therapy used to treat children and young people (CYP) with juvenile idiopathic arthritis (JIA) and non-infectious uveitis (NIU). However, the ...

NOTCH3-ECD is a specific IPAH biomarker, Cloud-Clone’s SEL147Hu ELISA Kit powers this breakthrough HUSTON, TX, UNITED STATES, March 17, 2026 /EINPresswire.com/ — A groundbreaking study published in ...

Antimitochondrial antibodies can be detected in patients with systemic lupus erythematosus (SLE) and appear prognostic.

When tracked across calves and over time, serum total protein can provide insights into calf health, management consistency ...

On July 4, 2025, researchers at the National Research Centre on Camel in Bikaner, Rajasthan, released findings that changed how experts think about antivenom production. The team worked with Camelus ...